Alan Glicklich

Insider Reports History

Entity
Individual
Location
C/O Chinook Therapeutics U.S., Inc., 1600 Fairview Ave. E., Seattle, WA
Signature
/s/ John Dunn, Esq., Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Alan Glicklich:

Stock Role Class Num Shares Value Price $ Report Date Ownership
CHINOOK THERAPEUTICS, INC. Chief Medical Officer Stock Option (Right to Buy) 223K $5.82M $26.12 Jun 16, 2021 Direct
CHINOOK THERAPEUTICS, INC. Chief Medical Officer Common Stock 7.89K $308K $39.03 Feb 11, 2022 Direct
CalciMedica, Inc. Director Director Stock Option (Right to Buy) 20K Jan 15, 2025 Direct
CHINOOK THERAPEUTICS, INC. Chief Medical Officer Restricted Stock Units (RSU) 11.3K Feb 10, 2022 Direct

Insider Reports Filed by Alan Glicklich

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CALC CalciMedica, Inc. Jan 15, 2025 1 $0 4 Jan 16, 2025 Director
CALC CalciMedica, Inc. Jan 15, 2025 0 $0 3 Jan 16, 2025 Director
KDNY CHINOOK THERAPEUTICS, INC. Feb 10, 2022 3 -$30.5K 4 Feb 14, 2022 Chief Medical Officer
KDNY CHINOOK THERAPEUTICS, INC. Oct 6, 2021 3 -$30.8K 4 Oct 8, 2021 Chief Medical Officer
KDNY CHINOOK THERAPEUTICS, INC. Jun 16, 2021 3 -$319K 4 Jun 17, 2021 Chief Medical Officer